trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Brain Neoplasms D001932 15 associated lipids
Breast Neoplasms D001943 24 associated lipids
Carcinoma D002277 18 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Cat Diseases D002371 12 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Chondrosarcoma D002813 9 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Zhang Z et al. Role of histone acetylation in activation of nuclear factor erythroid 2-related factor 2/heme oxygenase 1 pathway by manganese chloride. 2017 Toxicol. Appl. Pharmacol. pmid:29054681
Nagaraja SS et al. Effect of Trichostatin A on radiation induced epithelial-mesenchymal transition in A549 cells. 2017 Biochem. Biophys. Res. Commun. pmid:28993195
Song Y et al. Trichostatin A and 5-Aza-2'-Deoxycytidine influence the expression of cold-induced genes in Arabidopsis. 2017 Plant Signal Behav pmid:29027833
Zheng C et al. Histone Deacetylase Inhibitors Relax Mouse Aorta Partly through Their Inhibitory Action on L-Type Ca Channels. 2017 J. Pharmacol. Exp. Ther. pmid:28860353
Jorstad NL et al. Stimulation of functional neuronal regeneration from Müller glia in adult mice. 2017 Nature pmid:28746305
Fujikawa J et al. Kruppel-like factor 4 regulates matrix metalloproteinase and aggrecanase gene expression in chondrocytes. 2017 Cell Tissue Res. pmid:28856432
Jih G et al. Unique roles for histone H3K9me states in RNAi and heritable silencing of transcription. 2017 Nature pmid:28682306
Jiang F et al. Trichostatin A increases embryo and green plant regeneration in wheat. 2017 Plant Cell Rep. pmid:28752355
Bouzelfen A et al. Heterogeneous epigenetic regulation of HACE1 in Burkitt- Lymphoma-derived cells. 2017 Leuk. Res. pmid:28651105
Jayaraman A et al. The epigenetic drug Trichostatin A ameliorates experimental autoimmune encephalomyelitis via T cell tolerance induction and impaired influx of T cells into the spinal cord. 2017 Neurobiol. Dis. pmid:28736194
Gurgul A et al. The effect of histone deacetylase inhibitor trichostatin A on porcine mesenchymal stem cell transcriptome. 2017 Biochimie pmid:28552396
Ikeda K et al. In vitro drug testing based on contractile activity of C2C12 cells in an epigenetic drug model. 2017 Sci Rep pmid:28300163
Pandey P et al. Dynamics of post-translationally modified histones during barley pollen embryogenesis in the presence or absence of the epi-drug trichostatin A. 2017 Plant Reprod pmid:28526911
Anderson L et al. Histone deacetylase inhibition modulates histone acetylation at gene promoter regions and affects genome-wide gene transcription in Schistosoma mansoni. 2017 PLoS Negl Trop Dis pmid:28406899
Shao G et al. Inactivation of EGFR/AKT signaling enhances TSA-induced ovarian cancer cell differentiation. 2017 Oncol. Rep. pmid:28393191
Chang YW and Singh KP Long-term exposure to estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells. 2017 PLoS ONE pmid:28323900
Lin S et al. Silencing of ATP4B of ATPase H/K Transporting Beta Subunit by Intragenic Epigenetic Alteration in Human Gastric Cancer Cells. 2017 Oncol. Res. pmid:28281974
Li LF et al. Trichostatin A attenuates ventilation-augmented epithelial-mesenchymal transition in mice with bleomycin-induced acute lung injury by suppressing the Akt pathway. 2017 PLoS ONE pmid:28234968
Wu Y et al. Suppression of Excessive Histone Deacetylases Activity in Diabetic Hearts Attenuates Myocardial Ischemia/Reperfusion Injury via Mitochondria Apoptosis Pathway. 2017 J Diabetes Res pmid:28191472
Vanneste M et al. Hyaluronate synthase-2 overexpression alters estrogen dependence and induces histone deacetylase inhibitor-like effects on ER-driven genes in MCF7 breast tumor cells. 2017 Mol. Cell. Endocrinol. pmid:28137613
Wang XJ et al. Opposing Roles of Acetylation and Phosphorylation in LIFR-Dependent Self-Renewal Growth Signaling in Mouse Embryonic Stem Cells. 2017 Cell Rep pmid:28122243
Cao Z et al. TSA and BIX-01294 Induced Normal DNA and Histone Methylation and Increased Protein Expression in Porcine Somatic Cell Nuclear Transfer Embryos. 2017 PLoS ONE pmid:28114389
Huynh NC et al. Histone deacetylase inhibition enhances in-vivo bone regeneration induced by human periodontal ligament cells. 2017 Bone pmid:27871909
Staberg M et al. Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine. 2017 Cell Oncol (Dordr) pmid:27766591
Wisnieski F et al. BMP8B Is a Tumor Suppressor Gene Regulated by Histone Acetylation in Gastric Cancer. 2017 J. Cell. Biochem. pmid:27748538
Ladrech S et al. High mobility group box 1 (HMGB1): dual functions in the cochlear auditory neurons in response to stress? 2017 Histochem. Cell Biol. pmid:27704212
Hrgovic I et al. Histone deacetylase inhibitors interfere with angiogenesis by decreasing endothelial VEGFR-2 protein half-life in part via a VE-cadherin-dependent mechanism. 2017 Exp. Dermatol. pmid:27487811
Anantharaju PG et al. Induction of colon and cervical cancer cell death by cinnamic acid derivatives is mediated through the inhibition of Histone Deacetylases (HDAC). 2017 PLoS ONE pmid:29190639
Hartl M et al. Lysine acetylome profiling uncovers novel histone deacetylase substrate proteins in . 2017 Mol. Syst. Biol. pmid:29061669
Xie C et al. In vitro analysis of factors influencing expression as potential determinants of interindividual variation. 2017 Pharmacol Res Perspect pmid:28357125
Mijiddorj T et al. Retinoic acid and retinaldehyde dehydrogenase are not involved in the specific induction of the follicle-stimulating hormone β subunit by trichostatin A, a selective inhibitor of histone deacetylase. 2017 Gen. Comp. Endocrinol. pmid:26654743
Wang SC et al. Trichostatin A induces bladder cancer cell death via intrinsic apoptosis at the early phase and Sp1‑survivin downregulation at the late phase of treatment. 2017 Oncol. Rep. pmid:28713892
Pérez-Garrastachu M et al. Nucleoporins redistribute inside the nucleus after cell cycle arrest induced by histone deacetylases inhibition. 2017 Nucleus pmid:28696859
Opiela J et al. In vitro development and cytological quality of inter-species (porcine→bovine) cloned embryos are affected by trichostatin A-dependent epigenomic modulation of adult mesenchymal stem cells. 2017 Theriogenology pmid:28583605
Hou X et al. HDAC inhibitor TSA ameliorates mechanical hypersensitivity and potentiates analgesic effect of morphine in a rat model of bone cancer pain by restoring μ-opioid receptor in spinal cord. 2017 Brain Res. pmid:28559159
Ilicic M et al. Modulation of Progesterone Receptor Isoform Expression in Pregnant Human Myometrium. 2017 Biomed Res Int pmid:28540297
Duan HY et al. Effect of Histone Deacetylase Inhibition on the Expression of Multidrug Resistance-associated Protein 2 in a Human Placental Trophoblast Cell Line. 2017 Chin. Med. J. pmid:28524836
Androutsopoulos VP and Spandidos DA Antiproliferative effects of TSA, PXD‑101 and MS‑275 in A2780 and MCF7 cells: Acetylated histone H4 and acetylated tubulin as markers for HDACi potency and selectivity. 2017 Oncol. Rep. pmid:29039546
Wei W et al. Class I histone deacetylases are major histone decrotonylases: evidence for critical and broad function of histone crotonylation in transcription. 2017 Cell Res. pmid:28497810
Anantharaju PG et al. Naturally occurring benzoic acid derivatives retard cancer cell growth by inhibiting histone deacetylases (HDAC). 2017 Cancer Biol. Ther. pmid:28506198
Acun T et al. HLJ1 (DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer. 2017 OMICS pmid:28481734
Golfier S et al. High-throughput cell mechanical phenotyping for label-free titration assays of cytoskeletal modifications. 2017 Cytoskeleton (Hoboken) pmid:28445605
Kim YH and Lee JK Histone deacetylase inhibitors suppress immature dendritic cell's migration by regulating CC chemokine receptor 1 expression. 2017 Cell. Immunol. pmid:28341057
Pachano T et al. Epigenetics regulates transcription and pathogenesis in the parasite Trichomonas vaginalis. 2017 Cell. Microbiol. pmid:28054438
Cipriano M et al. The role of epigenetic modifiers in extended cultures of functional hepatocyte-like cells derived from human neonatal mesenchymal stem cells. 2017 Arch. Toxicol. pmid:27909741
Choi SA et al. A novel histone deacetylase inhibitor, CKD5, has potent anti-cancer effects in glioblastoma. 2017 Oncotarget pmid:27852054
Pinz S and Rascle A Assessing HDAC Function in the Regulation of Signal Transducer and Activator of Transcription 5 (STAT5) Activity Using Chromatin Immunoprecipitation (ChIP). 2017 Methods Mol. Biol. pmid:27761827
Buchou T et al. Purification and Analysis of Male Germ Cells from Adult Mouse Testis. 2017 Methods Mol. Biol. pmid:27761820
Unruhe-Knauf B and Knauer SK Analysis of HDACi-Induced Changes in Chromosomal Passenger Complex Localization. 2017 Methods Mol. Biol. pmid:27761812
Gilardini Montani MS et al. Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells. 2017 Cell Oncol (Dordr) pmid:28160167